Orgenesis (FRA:45O0) Other Long Term Assets : €0.36 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Other Long Term Assets?

Orgenesis's other long-term assets for the quarter that ended in Sep. 2024 was €0.36 Mil.

Orgenesis's quarterly other long-term assets declined from Mar. 2024 (€0.54 Mil) to Jun. 2024 (€0.54 Mil) but then stayed the same from Jun. 2024 (€0.54 Mil) to Sep. 2024 (€0.36 Mil).

Orgenesis's annual other long-term assets declined from Dec. 2021 (€1.76 Mil) to Dec. 2022 (€1.47 Mil) and declined from Dec. 2022 (€1.47 Mil) to Dec. 2023 (€0.05 Mil).

Orgenesis Other Long Term Assets Historical Data

The historical data trend for Orgenesis's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Other Long Term Assets Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

2.66

0.92

1.76

1.47

0.05

Orgenesis Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															0.80	0.05	0.54	0.54	0.36

Orgenesis Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Orgenesis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O0) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ORGS:USA

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Octomera and Therapies.

Orgenesis Headlines

No Headlines